Unum Therapeutics Inc. | Business Contracts

Sublease by and between Cogent Biosciences, Inc. and Cimpress USA Incorporated dated March 19, 2022 (Filed With SEC on August 9, 2022)

Form of Pre-Funded Warrant (Filed With SEC on June 16, 2022)

Cogent Biosciences, Inc. Underwriting Agreement (Filed With SEC on June 16, 2022)

Form of Pre-Funded Warrant (Filed With SEC on June 15, 2022)

Cogent Biosciences, Inc. Underwriting Agreement (Filed With SEC on June 15, 2022)

First Amendment to Lease by and between Cogent Biosciences, Inc. and BCSP Pearl East Property LLC dated March 29, 2022 (Filed With SEC on May 10, 2022)

Amended and Restated Cogent Biosciences, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 15, 2022)

Form of Director and Officer Indemnification Agreement (Filed With SEC on March 15, 2022)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 15, 2022)

Amended and Restated Employment Agreement entered into on December 24, 2021 by and between Cogent Biosciences, Inc. and Jessica Sachs, MD (Filed With SEC on December 27, 2021)

Amended and Restated Employment Agreement entered into on December 24, 2021 by and between Cogent Biosciences, Inc. and John Green (Filed With SEC on December 27, 2021)

Lease by and between Cogent Biosciences, Inc. and BCSP Pearl East Property LLC dated July 6, 2021 (Filed With SEC on July 9, 2021)

Cogent Biosciences, Inc. Amended and Restated 2018 Stock Option and Incentive Plan (Filed With SEC on June 17, 2021)

Employment Agreement dated as of February 1, 2021, between Cogent Biosciences, Inc. and Jessica Sachs (Filed With SEC on March 16, 2021)

Amended and Restated Cogent Biosciences, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 16, 2021)

Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on March 16, 2021)

Cogent Biosciences, Inc. 2018 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on March 16, 2021)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2021)

Cogent Biosciences, Inc. Underwriting Agreement (Filed With SEC on December 2, 2020)

Asset Purchase Agreement, dated August 28, 2020, by and among, Unum Therapeutics Inc. SOTIO LLC and SOTIO NV (Filed With SEC on November 9, 2020)

Employment Agreement, dated October 23, 2020, between Cogent Biosciences, Inc. and Andrew Robbins (Filed With SEC on November 9, 2020)

Separation Agreement entered into on October 22, 2020 by and between Cogent Biosciences, Inc. and Charles Wilson (Filed With SEC on October 26, 2020)

Cogent Biosciences, Inc. 2020 Inducement Plan and form of option award agreement thereunder (Filed With SEC on October 26, 2020)

Amendment to Employment Agreement entered into on October 19, 2020 by and between Cogent Biosciences, Inc. and John Green (Filed With SEC on October 23, 2020)

Contingent Value Rights Agreement, dated as of August 6, 2020, by and among Unum Therapeutics Inc., Computershare Inc. and Computershare Trust Company, N.A (Filed With SEC on August 10, 2020)

Securities Purchase Agreement, dated as of July 6, 2020, by and among Unum Therapeutics Inc. and each purchaser identified on Annex A thereto (Filed With SEC on July 6, 2020)

Agreement and Plan of Merger, dated July 6, 2020, by and among Unum Therapeutics Inc., Utah Merger Sub 1 LLC, Utah Merger Sub 2 LLC and Kiq LLC (Filed With SEC on July 6, 2020)

Form of Registration Rights Agreement, by and among Unum Therapeutics Inc. and certain purchasers (Filed With SEC on July 6, 2020)

Employment Agreement, dated July 6, 2020, between Unum Therapeutics Inc. and John L. Green (Filed With SEC on July 6, 2020)

Amendment to Employment Agreement, dated July 6, 2020, between Unum Therapeutics Inc. and Charles Wilson (Filed With SEC on July 6, 2020)

Amendment to Employment Agreement, dated July 6, 2020, between Unum Therapeutics Inc. and Jessica Sachs (Filed With SEC on July 6, 2020)

Employee Agreement by and between the Registrant and Seth Ettenberg, effective as of March 19, 2018 (Filed With SEC on May 11, 2020)

Description of Registrants Securities (Filed With SEC on March 26, 2020)

Registration Rights Agreement dated as of March 19, 2020 between Unum Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 20, 2020)

Purchase Agreement dated as of March 19, 2020 between Unum Therapeutics Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 20, 2020)

Consulting Agreement by and between the Registrant and Michael Vasconcelles dated as of July 25, 2019 (Filed With SEC on November 12, 2019)

Employment Agreement by and between the Registrant and Jessica Sachs dated as of July 15, 2019 (Filed With SEC on November 12, 2019)

Employment Agreement by and between the Registrant and Matthew Osborne dated as of June 17, 2019 (Filed With SEC on August 12, 2019)

Fourth Amendment to Loan and Security Agreement, dated as of July 31, 2019, by and between Unum Therapeutics Inc. and Pacific Western Bank (Filed With SEC on August 5, 2019)

Third Amendment to Loan and Security Agreement, dated as of June 21, 2019, by and between Unum Therapeutics Inc. and Pacific Western Bank (Filed With SEC on June 25, 2019)

First Amendment to Loan and Security Agreement with Pacific Western Bank dated as of July 6, 2018 (Filed With SEC on March 28, 2019)

Second Amendment to Loan and Security Agreement, dated as of January 18, 2019 by and between Unum Therapeutics Inc. and Pacific Western Bank (Filed With SEC on January 23, 2019)

Specimen Common Stock Certificate (Filed With SEC on March 19, 2018)

Unum Therapeutics Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 19, 2018)

Unum Therapeutics Inc. 2018 Employee Stock Purchase Plan (Filed With SEC on March 19, 2018)

Unum Therapeutics Inc. 2018 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on March 19, 2018)

Employment Agreement by and between the Registrant and Christiana Stamoulis (to be effective upon completion of this offering (Filed With SEC on March 19, 2018)

Employment Agreement by and between the Registrant and Michael Vasconcelles (to be effective upon completion of this offering (Filed With SEC on March 19, 2018)

Employment Agreement by and between the Registrant and Charles Wilson (to be effective upon completion of this offering (Filed With SEC on March 19, 2018)

Form of Officer Indemnification Agreement (Filed With SEC on March 19, 2018)

Form of Director Indemnification Agreement (Filed With SEC on March 19, 2018)

Loan and Security Agreement between the Registrant and Pacific Western Bank, dated as of January 19, 2017 (Filed With SEC on March 19, 2018)

2015 Amended and Restated Stock Incentive Plan, as amended, and forms of award agreements thereunder (Filed With SEC on March 19, 2018)

Form of Stock Purchase Agreement between the Registrant and Seattle Genetics, Inc (Filed With SEC on March 19, 2018)

Form of Underwriting Agreement (Filed With SEC on March 19, 2018)

Amended Investor Rights Agreement among the Registrant and certain of its stockholders, dated June 10, 2015 (Filed With SEC on March 2, 2018)

2015 Amended and Restated Stock Incentive Plan, as amended, and forms of award agreements thereunder (Filed With SEC on March 2, 2018)

Collaboration Agreement by and between the Registrant and Seattle Genetics, Inc., dated June 7, 2015 (Filed With SEC on March 2, 2018)

Amended and Restated Exclusive License Agreement dated November 15, 2015 (Filed With SEC on March 2, 2018)

Lease Agreement between the Registrant and King 200 CPD LLC, dated July 7, 2015 (Filed With SEC on March 2, 2018)

Loan and Security Agreement between the Registrant and Pacific Western Bank, dated as of January 19, 2017 (Filed With SEC on March 2, 2018)

Unum Therapeutics Inc. (61)